ROCHE News & Analysis

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far. 

These names from the Morningstar Exponential Technologies Index are trading at 4- and 5-star levels.

These undervalued wide-moat stocks earn low uncertainty ratings, writes Susan Dziubinski.

A new Morningstar report identifies which big-name health companies are inoculated against environmental, social and governance risks.

These high-quality companies, including Bristol-Myers Squibb, Roche and Imperial Brands, span a broad range of sectors and represent good value at...

Morningstar's Peter Bull likes companies with pricing power and niche products, and names that catch his eye include Microsoft, Colgate and luxury...

Australian investors are particularly prone to home-market bias, which could see them miss out on opportunities presented by spreading their risk...